Derma Sciences (DSCI) Gets CE Mark for MEDIHONEY HCS

Article Stock Quotes (1) Comments (0)

Derma Sciences, Inc. (Nasdaq: DSCI), announces receipt of the CE Mark for the Company’s patented MEDIHONEY HCS (hydrogel colloidal sheet) dressings. With this determination the entire current line of MEDIHONEY products has CE marking.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Depomed (DEPO) Reports Submission of ANDA for Generic Zipsor
• Final Conversion Ratio Offered by Pfizer (PFE) for Zoetis (ZTS) Shares is 0.9898
• CryoLife (CRY) Conditionally Approved to Start PerClot Trials in U.S.

Create E-mail Alert Related Categories

Corporate News, FDA

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?